Forvis Mazars Wealth Advisors LLC Sells 4,562 Shares of CVS Health Co. (NYSE:CVS)

Forvis Mazars Wealth Advisors LLC cut its holdings in CVS Health Co. (NYSE:CVS) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,936 shares of the pharmacy operator’s stock after selling 4,562 shares during the quarter. Forvis Mazars Wealth Advisors LLC’s holdings in CVS Health were worth $985,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the third quarter worth about $25,000. Legacy Investment Solutions LLC bought a new stake in shares of CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $32,000. Ridgewood Investments LLC grew its holdings in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. Finally, Stonebridge Financial Group LLC bought a new stake in CVS Health in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.24% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several research analyst reports. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. UBS Group decreased their target price on CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a research note on Tuesday, February 11th. Leerink Partnrs raised CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 12th. Wells Fargo & Company boosted their price objective on CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. Finally, Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $70.00.

CVS Health Trading Down 2.6 %

CVS Health stock opened at $63.42 on Monday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The firm has a 50-day moving average of $52.39 and a 200-day moving average of $56.20. The company has a market cap of $79.95 billion, a price-to-earnings ratio of 17.33, a P/E/G ratio of 0.98 and a beta of 0.61. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.19%. CVS Health’s dividend payout ratio is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.